From: Fulminant proliferative vitreoretinopathy in syphilitic uveitis
Case | Initial BCVA | Laboratory results | Presentation of posterior uveitis | Duration of treatment | Outcome after treatmenta | Final BCVA |
---|---|---|---|---|---|---|
Case 1 | OD: 20/63 | Serum: + VDRL: 1/512 + TPHA | OD: PRI | Intravenous penicillin: 14 days | OD: Macular pucker (21 weeks) | OD: 20/63 |
OS: HM | CSF: + VDRL Pleocytosis HIV: negative | OS: PRI, NRC | Prednisone: 60 mg/day (tapering regimen for 7 weeks) | OS: Tractional RD (8 weeks) | OS: CF | |
Case 2 | OD: HM | Serum: + VDRL: 1/1024 + TPHA | OD: NRC | Intravenous penicillin: 21 days | OD: Mixed RD (2 weeks) | OD: LP |
OS: HM | CSF: + VDRL Pleocytosis HIV: positive | OS: NRC | Prednisone: 60 mg/day (tapering regimen for 7 weeks) | OS: Mixed RD (1 week) | OS: 20/150 | |
Case 3 | OD: CF | Serum: + VDRL:1/4096 + THPA | OD: NRC | Intravenous penicillin: 21 days | OD: Macular Pucker (5 weeks) | OD: 20/250 |
OS: HM | CSF: + VDRL Pleocytosis HIV: negative | OS: PPCR, PRI, NRC | Prednisone: 60 mg/day (tapering regimen for 10 weeks) | OS: Mixed RD (4 weeks) | OS: HM | |
Case 4 | OD: HM | Serum: + VDRL: 1/512 + THPA | OD: NRC | Intravenous penicillin: 21 days | OD: Tractional RD (2 weeks) | OD: NLP |
OS: 20/200 | CSF: − VDRL HIV: positive | OS: Optic disc hyperemia, vascular sheathing | Prednisone: 60 mg/day (tapering regimen for 4 weeks) | OS: No lesions | OS: 20/20 |